000			01477 a2200409 4500
005			20250513115226.0
264		0	_c19970603
008			199706s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aSalhany, K E
245	0	0	_aCytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. _h[electronic resource]
260			_bBlood _cMay 1997
300			_a3490-1 p. _bdigital
500			_aPublication Type: Comment; Letter; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aChromosomes, Human, Pair 7
650	0	4	_aCyclophosphamide
650	0	4	_aDoxorubicin
650	0	4	_aHumans
650	0	4	_aKidney Transplantation
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aLymphoma, T-Cell _xdrug therapy
650	0	4	_aPostoperative Complications
650	0	4	_aPrednisolone
650	0	4	_aReceptors, Antigen, T-Cell, alpha-beta _xgenetics
650	0	4	_aReceptors, Antigen, T-Cell, gamma-delta _xgenetics
650	0	4	_aSplenic Neoplasms _xdrug therapy
650	0	4	_aT-Lymphocyte Subsets _ximmunology
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aTrisomy
650	0	4	_aVincristine
700	1		_aFeldman, M
700	1		_aPeritt, D
700	1		_aNowell, P C
773	0		_tBlood _gvol. 89 _gno. 9 _gp. 3490-1
999			_c9110579 _d9110579